**About the Special Issue Editors**

**Joachim Jankowski** is Director of the Institute of Molecular Cardiovascular Research (IMCAR) at the University Hospital Aachen and RWTH Aachen University, Germany. This institute strives for scientific excellence in the field of cardiovascular diseases with a particular focus on patients with chronic renal insufficiency. Research is performed in close collaboration with the Cardiovascular Research Institute of the partner University of Maastricht (CARIM) in the Netherlands. Prof. Dr. Jankowski is the Speaker of the Transregional Collaborative Research Consortium SFB/TRR219 funded by the German Research Foundation (2018–2021). He is the Coordinator of the Marie Skłodowska-Curie International Training Network "CaReSyAn" (2018–2021).

**Heidi Noels** is leading the research group "Experimental Cardiovascular Pathophysiology" in the Institute of Molecular Cardiovascular Research (IMCAR) at the RWTH Aachen University, Germany. Her group is focusing on the identification and characterization of pathological mechanisms and mediators underlying cardiovascular and cardiorenal disease. Dr. Noels is Managing Director of the Transregional Collaborative Research Consortium SFB/TRR219 funded by the German Research Foundation (2018–2021) and Program Manager of the Marie Skłodowska-Curie International Training Network "CaReSyAn" (2018–2021).

This Special Issue was created in the context of the SFB/TRR219 Research Consortium funded by the German Research Foundation (Project-ID 322900939) and the European Union's Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 764474 (CaReSyAn).
